Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Financial Disclosure
The University of Florida Medical School provided all outside activity disclosure data for faculty from forms filed from 2016 through June 2019. Faculty are required to report outside activities that could give rise to an appearance of conflict of interest and get approval for them.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Kenneth Cusi
University of Florida, Department: Md Endocrinology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Prosciento
Provide my expertise about to this company that interacts with pharma on cutting-edge research for the treatment of fatty liver disease and NASH. The company provides advice on how to conduct clinical trials and interact with FDA. The consultants are a group of experts to assist in general logistical issues and the latest in the field. The meeting will be held on 4/11/2019 during the evening of from 6:30-9:30 pm as a satellite activity to the European Association for the study of Liver Disease annual meeting in Vienna (EASL meeting being held between 4/10 and 4/13/2019 reason why additional leave not requested). No IP expected, this is an update to the exact type of meeting held and approved by your office in November in San Francisco. I have reported this in an email sent to Brian and Zana on Wednesday, March 13, 2019 6:12 PM.
This will be a forum to discuss challenges in the field for a company that gives advice about conducting clinical trials in fatty liver disease. We will be 6-8 experts giving general advice on how to conduct these studies and related treatment developments in the field. We would meet every 6 months live for 2 hours. Our interest is to help pharmaceutical companies to do studies based on a standard within the scientific field and avoid methodological errors.
Filed on February 14, 2019.
Tell us what you know about Kenneth Cusi's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Kenneth Cusi”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Kenneth Cusi | University of Florida | Financial Disclosure | Novo Nordisk | |
| Kenneth Cusi | University of Florida | Financial Disclosure | Janssen Pharmaceutical | |
| Kenneth Cusi | University of Florida | Financial Disclosure | Poxel | |
| Kenneth Cusi | University of Florida | Financial Disclosure | Chronic Liver Disease Foundation | |
| Kenneth Cusi | University of Florida | Financial Disclosure | Allergan, Inc. | |
| Kenneth Cusi | University of Florida | Financial Disclosure | Novo Nordisk | |
| Kenneth Cusi | University of Florida | Financial Disclosure | Bristol-Myers Squibb Company (BMS) | |
| Kenneth Cusi | University of Florida | Financial Disclosure | DeuteRx | |
| Kenneth Cusi | University of Florida | Financial Disclosure | Merck |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.